In vitro determination of self-reactivity in the early postcyclosporine period.

作者: Ralf Huss

DOI: 10.1016/0966-3274(93)90051-9

关键词:

摘要: Abstract Since cyclosporine A(CsA) was introduced into transplantation medicine to prevent graft-versus-host disease (GvHD) as well graft rejection, side-effects became obvious. When CsA is given and withdrawn GvHD-like symptoms can occur even in an autologous setting. To understand this mechanism we tested the allo- self-reactivity of murine spleen lymphocytes vitro assay. Mice four different strains with two distinct MHC class I backgrounds (H-2 d H-2 k ) were treated 60 mg/kg/day intraperiteonally for ten days. In attempt examine possibility that CsA-induced autoimmunity requires presence thymus, half these four- six-week-old mice also thymectomized prior treatment. Within one day after stopped, all received during treatment showed reactivity against self-MHC-bearing cells. This demonstrated a primary stimulation assay followed by chromium-release -anti-H-2 ). However, alloreactivity suppressed. At point time, no natural killer (NK) activity detectable any CsA-treated mice. The days stopping CsA, autoreactivity longer mouse strain, whether or not, whereas NK finally recovered. phenomena self-reactivity, which occurred between 10 withdrawal, could be adoptively transferred from syngeneic reactive T cell populations identical sublethally irradiated recipients autoreactive cells died within 10–20 days, showing clinical signs pseudo GvHD (pGvHD). Irradiated control not receiving self-reactive cells, but irradiated, survived without complications. Our results suggest existence MHC-restricted which, under normal immunological conditions, are regulated probably nonfunctional vivo . other immunomodulatory manipulations may interfere maintainance self-tolerance lead activation role thymus at stage selection clear, since show has effect on mature periphery.

参考文章(19)
C. A. Shinn, G. W. Santos, W. E. Beschorner, J. D. Namnoum, A. D. Hess, Cyclosporin A and the thymus. Immunopathology. American Journal of Pathology. ,vol. 126, pp. 487- 496 ,(1987)
S Charan, A W Huegin, A Cerny, H Hengartner, R M Zinkernagel, Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice. Journal of Virology. ,vol. 57, pp. 1139- 1144 ,(1986) , 10.1128/JVI.57.3.1139-1144.1986
William E. Beschorner, Kelly A. Di Gennaro, Allan D. Hess, George W. Santos, Cyclosporine and the thymus: Influence of irradiation and age on thymic immunopathology and recovery Cellular Immunology. ,vol. 110, pp. 350- 364 ,(1987) , 10.1016/0008-8749(87)90128-6
WILLIAM E. BESCHORNER, HUA REN, JEFFREY PHILLIPS, HECTOR B. PULIDO, RALPH H. HRUBAN, ALLAN D. HESS, Prevention of syngeneic graft-versus-host disease by recovery of thymic microenvironment after cyclosporine. Transplantation. ,vol. 52, pp. 668- 674 ,(1991) , 10.1097/00007890-199110000-00017
M. Jenkins, R. Schwartz, D. Pardoll, Effects of cyclosporine A on T cell development and clonal deletion. Science. ,vol. 241, pp. 1655- 1658 ,(1988) , 10.1126/SCIENCE.3262237
Er-Kai Gao, David Lo, Richard Cheney, Osami Kanagawa, Jonathan Sprent, Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature. ,vol. 336, pp. 176- 179 ,(1988) , 10.1038/336176A0